Champions Oncology to Present Posters on TumorGraft Application in Clinical and Research Settings at AACR Annual Meeting 2014

Hackensack, NJ – April 4, 2014 – Champions Oncology, Inc. (OTC : CSBR) a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the presentation of data from applications of Champions TumorGrafts® in clinical and research settings in multiple presentations at the American Association for Cancer Research (AACR) Annual Meeting 2014.

The presentations will be delivered during the general poster session in Halls A-E of the San Diego Convention Center from 8 a.m. to noon PDT on Monday, April 7.

Presentation Details

Title : The Champions TumorGraft® Bank : A demographically-rich repository of preclinical TumorGraft models
Presented By : Tin Khor, Ph.D., Champions Oncology
Location : Section 8, Poster Board 6
Abstract Number : 1187

Title : Multifactorial biological processes govern engraftment of patient-derived tumor tissue in immunodeficient mice
Presented By : David Vasquez-Dunddel, M.D., Ph.D., Champions Oncology
Location : Section 8, Poster Board 9
Abstract Number : 1190

Title : Humanized mouse models for personalized preclinical testing of monoclonal antibodies targeting immune checkpoints
Presented By : Gilson Baia, Ph.D., Champions Oncology
Location : Section 28, Poster Board 28
Abstract Number : 1674

Title : Development of a spontaneous in vivo cachexia model using the Champions TumorGraft® platform
Presented By : Nathan Anderson, Champions Oncology
Location : Section 9, Poster Board 14
Abstract Number : 1217

Title : Efficacy of FASN-selective small molecule inhibitors in preclinical tumor models
Presented By : Timothy Heuer, Ph. D., 3-V Bio sciences
Location : Section 33, Poster Board 28
Abstract Number : 1815